AutoZone's stock sinks toward 7-month low after rival Advance Auto Parts' disappointing results, dividend cut
Shares of AutoZone Inc. (AZO) sank 6.4% toward a 7-month low in premarket trading Wednesday, in the wake of a disappointing earnings report from rival auto parts seller Advance Auto Parts Inc. (AAP), which included cuts to its full-year guidance and its dividend amid a competitive pricing environment. AutoZone had reported last week a quarterly profit beat but sales that missed, citing weaker-than-expected March sales. At that time, AutoZone Chief Executive Officer William Rhodes had said he'd seen a competitor move their pricing, but saw no indications that competitor's pricing was lower than AutoZone's. Meanwhile, shares of other auto parts sellers also fell, with O'Reilly Automotive Inc.'s stock (ORLY) down 5.5% toward a 7-week low and Genuine Parts Co.'s stock (GPC) down 5.0% toward an 8-month low.
-Tomi Kilgore
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-31-23 0848ET
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Powell Unfazed By Sticky Inflation, but Rate Cuts Are Far Off
-
After Earnings, Is Microsoft Stock a Buy, a Sell, or Fairly Valued?
-
Best- and Worst-Performing Stocks of April 2024
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
10 Top-Performing Dividend Stocks of the Month
-
Marathon Petroleum Earnings: No Change to Competitive Position, but Shares Look Expensive
-
Charlie Munger and How Not to Invest
-
Look Inside Berkshire Hathaway’s Portfolio Before Its Annual Meeting
-
After Earnings, Is AT&T Stock a Buy, a Sell, or Fairly Valued?
-
Mastercard Earnings: A Stable Environment Highlights the Firm’s Strengths
-
Pfizer Earnings: Solid Results Supported by Steady Tracking Toward $4 Billion In Cost Cuts
-
Starbucks Earnings: Not a Lot to Like About Results as Global Traffic Sputters